Yüklüyor......
Therapeutic Advances in Functional Gastrointestinal Disease: Irritable Bowel Syndrome
Reported prevalence rates of irritable bowel syndrome (IBS) are between 8% to 20% in the US general population with an average medical expenditure of US$1.35 billion direct and US$205 million indirect costs. Current pathophysiologic theories are based on abnormalities of both the brain and gut, thus...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2779541/ https://ncbi.nlm.nih.gov/pubmed/19936327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X08103656 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|